Abstract
Charcot–Marie–Tooth type 1A (CMT1A) represents 80% of all the demyelinating hereditary motor and sensory neuropathies. As recently suggested, neuroactive steroids may have a role in a therapeutic strategy for peripheral neuropathies, including CMT1A. To this aim, an accurate qualitative and quantitative analysis of neuroactive steroid levels in this disease could be extremely important to define effective pharmacological strategies. We here analyzed by liquid chromatography-tandem mass spectrometry the levels of neuroactive steroids present in the sciatic nerve of male and female peripheral myelin protein 22 transgenic rats (PMP22tg rats; i.e., an experimental model of CMT1A) and of the corresponding wild-type littermates. We observed that, both in PMP22tg rats and in the wild types, the levels of neuroactive steroids, such as progesterone, tetrahydroprogesterone (THP), isopregnanolone (3β,5α-THP), testosterone, dihydrotestosterone, and 5α-androstane-3α, 17β-diol (3α-diol) are sexually dimorphic. It is interesting to note that the levels of 3β,5α-THP and of 3α-diol, which are exclusively detectable in sciatic nerve of female and male rats, respectively, are strongly decreased in PMP22tg rats. 3β,5α-THP and 3α-diol are modulators of gamma-amino butyric acid A receptor. Thus, the present findings may be considered an interesting background for experiments aimed to evaluate the possible therapeutic effects of modulators of this neurotransmitter receptor in male and female PMP22tg rats.
References
Azcoitia, I., Leonelli, E., Magnaghi, V., Veiga, S., Garcia-Segura, L.M., & Melcangi, R.C. (2003). Progesterone and its derivatives dihydroprogesterone and tetrahydroprogesterone reduce myelin fiber morphological abnormalities and myelin fiber loss in the sciatic nerve of aged rats. Neurobiology of Aging, 24, 853–860.
Backström, T., Wahlstrom, G., Wahlstrom, K., Zhu, D., & Wang, M-D. (2005). Isoallopregnanolone; an antagonist to the anaesthetic effect of allopregnanolone in male rats. European Journal of Pharmacology, 512, 15–21.
Belelli, D., & Lambert, J.J. (2005). Neurosteroids: Endogenous regulators of the GABA(A) receptor. Nature Reviews: Neuroscience, 6, 565–575.
Bitran, D., Hilvers, R.J., & Kellog, C.K. (1991). Anxiolytic effects of 3alpha-hydroxy-5alpha (beta)-pregnan-20-one: Endogenous metabolites of progesterone that are active at the GABAA receptor. Brain Research, 561, 157–161.
Caruso, D., Scurati S., Maschi O. et al. (2007) Evaluation of neuroactive steroid levels by liquid chromatography–tandem mass spectrometry in central and peripheral nervous system: Effect of diabetes. Neurochemistry International (in press), DOI 10.1016/j.neuint.2007.06.004.
Frye, C.A., Van Keuren, K.R., & Erkine, M.S. (1996). Behavioral effects of 3alpha-androstanediol. I: Modulation of sexual receptivity and promotion of GABA-stimulated chloride flux. Behavioural Brain Research, 79, 109–118.
Gee, K.W., Chang, W-C., Brinton, R.E., & McEwen, B.S. (1987). GABA-dependent modulation of the Cl− ionophore by steroids in rat brain. European Journal of Pharmacology, 136, 419–423.
Gee, K.W., Bolger, M.B., Brinton, R.E., Coirini, H., & McEwen, B.S. (1988). Steroid modulation of the chloride ionophore in rat brain: Structure–activity requirements, regional dependence and mechanism of action. Journal of Pharmacology and Experimental Therapeutics, 246, 803–812.
Hanemann, C.O., & Muller, H.W. (1988). Pathogenesis of Charcot–Marie–Tooth type 1A neuropathy. Trends in Neurosciences, 21, 282–286.
Huppenbauer, C.B., Tanzer, L., DonCarlos, L.L., & Jones, K.J. (2005). Gonadal steroid attenuation of developing hamster facial motoneuron loss by axotomy: Equal efficacy of testosterone, dihydrotestosterone, and 17-beta estradiol. Journal of Neuroscience, 25, 4004–4013.
Joseph, E.K., & Levine, J.D. (2003a). Sexual dimorphism for protein kinase c epsilon signaling in a rat model of vincristine-induced painful peripheral neuropathy. Neuroscience, 119, 831–838.
Joseph, E.K., & Levine, J.D. (2003b). Sexual dimorphism in the contribution of protein kinase C isoforms to nociception in the streptozotocin diabetic rat. Neuroscience, 120, 907–913.
Koenig, H.L., Schumacher, M., Ferzaz, B., et al. (1995). Progesterone synthesis and myelin formation by Schwann cells. Science, 268, 1500–1503.
Kovacic, U., Zele, T., Osredkar, J., Sketelj, J., & Bajrovic, F.F. (2004). Sex-related differences in the regeneration of sensory axons and recovery of nociception after peripheral nerve crush in the rat. Experimental Neurology, 189, 94–104.
Leonelli, E., Bianchi, R., Cavaletti, G., et al. (2007). Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: A multimodal analysis. Neuroscience, 144, 1293–1304.
Lundgren, P., Strömberg, J., Backström, T., & Wang, M. (2003). Allopregnanolone-stimulated GABA-mediated chloride ion flux is inhibited by 3β-hydroxy-5α-pregnan-20-one (isoallopregnanolone). Brain Research, 982, 45–53.
Lupski, J.R., de Oca-Luna, R.M., Slaugenhaupt, S., et al. (1991). DNA duplication associated with Charcot–Marie–Tooth disease type 1A. Cell, 66, 219–232.
Magnaghi, V., Veiga, S., Ballabio, M., Gonzalez, L.C., Garcia-Segura, L.M., & Melcangi, R.C. (2006). Sex-dimorphic effects of progesterone and its reduced metabolites on gene expression of myelin proteins by rat Schwann cells. Journal of the Peripheral Nervous System, 11, 112–119.
Melcangi, R.C., Magnaghi, V., Cavarretta, I., Martini, L., & Piva, F. (1998). Age-induced decrease of glycoprotein P0 and myelin basic protein gene expression in the rat sciatic nerve. Repair by steroid derivatives. Neuroscience, 85, 569–578.
Melcangi, R.C., Magnaghi, V., Cavarretta, I., et al. (1999). Progesterone derivatives are able to influence peripheral myelin protein 22 and P0 gene expression: Possible mechanisms of action. Journal of Neuroscience Research, 56, 349–357.
Melcangi, R.C., Magnaghi, V., Galbiati, M., Ghelarducci, B., Sebastiani, L., & Martini, L. (2000). The action of steroid hormones on peripheral myelin proteins: A possible new tool for the rebuilding of myelin? Journal of Neurocytology, 29, 327–339.
Meyer zu Horste, G., Prukop, T., Liebetanz, D., Mobius, W., Nave, K., & Sereda, M. (2007). Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy. Annals of Neurology, 61, 61–72.
Moore, C.L., & White, R.H. (1996). Sex differences in sensory and motor branches of the pudendal nerve of rat. Hormones and Behavior, 30, 590–599.
Padua, L., Aprile, I., Cavallaro, T., et al. (2006). Variables influencing quality of life and disability in Charcot Marie Tooth (CMT) patients: Italian multicentre study. Neurological Sciences, 27, 417–423.
Roglio, I., Bianchi, R., Giatti, S., et al. (2007). Testosterone derivatives are neuroprotective agents in experimental diabetic neuropathy. Cellular and Molecular Life Sciences, 64, 1158–1168.
Schumacher, M., Guennoun, R., Stein, D. G., & De Nicola, A. F. (2007). Progesterone: Therapeutic opportunities for neuroprotection and myelin repair. Pharmacology & Therapeutics, 116, 77–106.
Sereda, M., Griffiths, I., Pühlhofer, A., et al. (1996). A transgenic rat model of Charcot–Marie–Tooth disease. Neuron, 16, 1049–1060.
Sereda, M.W., Meyer zu Horste, G.W., Suter, U., Uzma, N., & Nave, K.A. (2003). Therapeutic administration of progesterone antagonist in a model of Charcot–Marie–Tooth disease (CMT-1A). Nature Neuroscience, 9, 1533–1537.
Veiga, S., Leonelli, E., Beelke, M., Garcia-Segura, L.M., & Melcangi, R.C. (2006). Neuroactive steroids prevent peripheral myelin alterations induced by diabetes. Neuroscience Letters, 402, 150–153.
Wang, M., He, Y., Eisenman, L.N., et al. (2002). 3β-Hydroxypregnane steroids are pregnenolone sulfate-like GABAA receptor antagonists. Journal of Neuroscience Research, 22, 3366–3375.
Acknowledgments
The financial supports of PRIN (2005060584_004), FIRST from University of Milan, Italy, and “Ricerca Finalizzata Ministero della Salute n. 2005/51” to R.C.M. are gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Caruso, D., Scurati, S., Roglio, I. et al. Neuroactive Steroid Levels in a Transgenic Rat Model of CMT1A Neuropathy. J Mol Neurosci 34, 249–253 (2008). https://doi.org/10.1007/s12031-007-9029-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-007-9029-3